-
3.52025 Impact Factor
-
5.42025 CiteScore
Editor-in-Chief
Robert E. Campbell
Associate Editors
Feng Ni
Evamaria I. Petersen
Arne Skerra
Tim Whitehead
View the full Editorial Board
PEDS 40th Anniversary: Protein Engineering: Status Report
In honour of the 40th anniversary of Protein Engineering, Design and Selection (PEDS), Protein Engineering: Status Report brings together contributions from leading researchers across the field to provide a comprehensive overview of, and perspective on, the current state of protein engineering and its future directions.
Read the landmark open access article
Email alerts
Register to receive email alerts as soon as new content from PEDS is published online.
Sign up
Latest Special Collections & Issues

Special Collection: Computational Methods for Protein Design
This special collection comprises 10 articles delving into some of the most rapidly advancing topics in computational protein design, from the design of intrinsically disordered proteins to the modelling of antibodies using deep-learning-based inverse folding.
Browse the collection

Special Collection: Enzyme Engineering
Protein Engineering, Design and Selection is pleased to publish a special collection of articles on enzyme engineering, a dynamic and interdisciplinary research field that aims to harness the potential of nature’s catalysts by optimizing their performance for a wide range of applications. In this special collection, you will explore the latest developments, strategies, and achievements in enzyme manipulation.
Browse the collection

High-Impact Research Collection
Explore a collection of the most read and most cited articles making an impact in PEDS published within the past two years. This collection will be continuously updated with the journal's leading articles so be sure to revisit periodically to see what is being read and cited.
Browse the collection

Special Collections & Issues from PEDS
In addition to its regular issues, Protein Engineering, Design and Selection publishes Special Collections and Special Issues comprising of reviews and articles centered on various topics within the field of proteins.
View the full list of current and previous collections and issues
Article Types

Methods
PEDS Methods papers describe at least one method or approach that is of broad interest to the field. They should include sufficient technical information to be followed by those in the field not previously familiar with it.
Browse this article type

Reviews
Our Reviews inform readers of the state-of-the-art in different areas of the discipline, providing a critical view or a historical perspective.
Browse this article type

Short Communications
Short communications in PEDS can announce new and focused research findings, useful computer software and its uses, and the announcement of novel protocols.
Browse this article type

PEDS Webinars
Watch recordings from all eight PEDS Protein Engineering and Design Webinars, providing updates on the latest developments from leading researchers sharing the future of the field.
View now

Read and Publish deals
Authors interested in publishing in PEDS may be able to publish their paper Open Access using funds available through their institution’s agreement with OUP.
Find out if your institution is participating

Committee on Publication Ethics (COPE)
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE)
publicationethics.org
ProteinMPNN is widely used in protein design workflows due to its ability to identify amino acid sequences that fold into specific 3D protein structures. In our work, we adjust ProteinMPNN to design proteins for a given 3D protein structure with reduced immune-visibility to cytotoxic T lymphocytes that recognize proteins ...
Nanobodies offer unique advantages in biomedical and biotechnological applications due to their smaller size, ability to bind challenging epitopes, and affordable production using recombinant technology. However, challenges in large-scale production, stability, and solubility limit their widespread use. To address this, we ...
Tuning in vivo activity of protein therapeutics can improve their safety. In this vein, it is possible to add a ‘mask’ moiety to a protein therapeutic such that its ability to bind its target is prevented until the mask has been proteolytically removed, for instance by a tumor-associated protease. As such, new methods to ...
The evolution of antibody engineering has significantly enhanced the development of antibody-based therapeutics, enabling the creation of novel antibody formats tailored for specific applications. Since the introduction of the Kabat numbering scheme in 1977, various schemes have been developed and modified, forming the ...
Yeast display is a widely used technology in antibody discovery and protein engineering. The cell size of yeast enables fluorescence-activated cell sorting (FACS) to precisely screen gene libraries, including for multi-parameter selection of protein phenotypes. However, yeast cells show a broader size distribution than ...
Non-canonical amino acids (ncAAs) are versatile molecular building blocks that can enhance nearly every aspect of protein engineering, from improving binding affinity to enabling precise quantitative analyses. This review highlights advances from 2020–2025 that demonstrate how expanding the amino acid repertoire unlocks ...
Precise control of substrate transport across compartment boundaries is critical for the design of enzymatic nanoreactors, yet selective and tunable molecular flux remains a major bottleneck in confined reaction systems. Outer membrane porins offer a promising solution, as their transport ...
From protein structure prediction to novel protein generation, challenging protein engineering tasks have been made possible by advancements in machine learning (ML). While largely driven by ML architecture refinements, these advancements in ML-based protein engineering campaigns have left the ...
Small protein ligands, such as miniproteins, have the potential to provide the efficient physiological transport and rapid clearance required for radioligand therapy. Yet, binders require single-digit nanomolar affinity for potent targeting and high stability for radiolabeling and physiological ...
Calreticulin is an emerging cancer biomarker, but current detection methods rely on expensive monoclonal antibodies that suffer from inefficient protein production, pharmacokinetic challenges and poor tissue penetration. Cal3, a calreticulin-specific nanobody, was constructed by replacing the ...
Antibody prodrugs represent a promising therapeutic format that provides advantages compared to conventional monoclonal antibody therapeutics. In this study, we engineered an antibody prodrug using an anti-P-selectin antibody as a model system, incorporating N-terminal heavy chain extensions ...
Rapid and scalable protein binder discovery platforms are essential for accelerating therapeutic and diagnostic development. Click display is a cell-free protein display technology that covalently links nascent proteins to their encoding cDNA in a one-pot reaction within 2 h, enabling rapid in ...
Thermophile-derived enzymes are of interest for cell-free biocatalysis due to their intrinsic thermostability, which simplifies purification via heat treatment and correlates with enhanced activity retention under cell-free reaction conditions. However, thermal stability often comes at the expense ...
As demand for the rare earth elements (REEs) that power new and emerging technologies increases rapidly, there is a growing need for next-generation separations systems that can provide more selective isolation of these critical, but difficult-to-purify materials. Due to their evolvability and ...
